Virginia Di Paolo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Identification of a miRNAs signature as potential biomarker of mesenchymal phenotype in neuroblastoma patients.

Identification of a miRNAs signature as potential biomarker of mesenchymal phenotype in neuroblastoma patients.

Journal: Biomarker research

Published: May 30, 2025

Case Report: Proteomic analysis of cerebrospinal fluid in a retinoblastoma patient.

Case Report: Proteomic analysis of cerebrospinal fluid in a retinoblastoma patient.

Journal: Frontiers in oncology

Published: October 15, 2024

Toward a role for the acoustic field in cells interaction.

Toward a role for the acoustic field in cells interaction.

Journal: Frontiers in systems neuroscience

Published: August 28, 2024

Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma.

Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 11, 2024

Increased miR-21-3p levels in extracellular vesicles of children with food anaphylaxis.

Increased miR-21-3p levels in extracellular vesicles of children with food anaphylaxis.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: May 23, 2024

Organoids as a new approach for improving pediatric cancer research.

Organoids as a new approach for improving pediatric cancer research.

Journal: Frontiers in oncology

Published: April 08, 2024

Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patients.

Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patients.

Journal: Frontiers in immunology

Published: June 02, 2023

Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma.

Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma.

Journal: Life (Basel, Switzerland)

Published: February 23, 2023

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Journal: JCO precision oncology

Published: October 20, 2022

Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript.

Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript.

Journal: International journal of molecular sciences

Published: March 16, 2021

Neuroblastoma-secreted exosomes carrying miR-375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells.

Neuroblastoma-secreted exosomes carrying miR-375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells.

Journal: Journal of extracellular vesicles

Published: September 14, 2020

Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding.

Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding.

Journal: Cancers

Published: May 07, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026